The website will promote its EcoVag range that include products based on patented probiotic strains that can be taken orally or applied to the vaginal area, and have been shown in studies to benefit vaginal conditions such as vaginosis.
“Bifodan is one of just a couple of companies that, based on this research approach, has successfully commercialised clinical documented concepts addressing vaginal health,” said Bifodan business development officer, Niels Peter Bak.





